1. Hiramatsu, K., Hanaki, H., Ino, T., Yabuta, K., Oguri, T.& Tenover, F. C. (1997). Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. Journal of Antimicrobial Chemotherapy40, 135–6.
2. British Society for Antimicrobial Chemotherapy. (1991). A Guide to Sensitivity Testing. Report of the Working Party on Antibiotic Sensitivity Testing of the British Society for Antimicrobial Chemotherapy. Academic Press, London.
3. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically—Fourth Edition: Approved Standard M7-A4. NCCLS, Wayne, PA.
4. Centers for Disease Control and Prevention. (1997). Staphylococcus aureus with reduced susceptibility to vancomycin—United States. Morbidity and Mortality Weekly Report46, 765–6.
5. Ploy, M. C., Grelaud, C., Martin, C., de Lumley, L.& Denis, F. (1998). First clinical isolate of vancomycin-intermediate Staphylococcus aureusin a French hospital. Lancet351,1212 .